• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌司奴单抗致年轻女性致死性急性心力衰竭:1 例报告。

Ustekinumab-Induced Fatal Acute Heart Failure in a Young Female: A Case Report.

机构信息

Texas Tech University Health Sciences Center, Lubbock, Texas, US.

Medical Research Institute, Alexandria University, Alexandria, Egypt.

出版信息

Methodist Debakey Cardiovasc J. 2022 Jul 12;18(1):54-58. doi: 10.14797/mdcvj.1076. eCollection 2022.

DOI:10.14797/mdcvj.1076
PMID:35891701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9284982/
Abstract

Data regarding short- and long-term cardiovascular complications of biological agents is lacking. Herein, the authors reported a case of abrupt onset of acute heart failure induced by ustekinumab treatment for resistant pityriasis rubra pilaris in a young healthy female with no past cardiac history. Although medical management was immediately initiated for cardiogenic shock, the patient passed away.

摘要

有关生物制剂的短期和长期心血管并发症的数据尚缺乏。在此,作者报告了一例年轻健康女性因难治性毛发红糠疹使用乌司奴单抗治疗后突发急性心力衰竭的病例,该患者既往无心脏病史。尽管立即启动了针对心源性休克的药物治疗,但患者仍死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a02/9284982/d52331c22c6d/mdcvj-18-1-1076-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a02/9284982/d52331c22c6d/mdcvj-18-1-1076-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a02/9284982/d52331c22c6d/mdcvj-18-1-1076-g1.jpg

相似文献

1
Ustekinumab-Induced Fatal Acute Heart Failure in a Young Female: A Case Report.乌司奴单抗致年轻女性致死性急性心力衰竭:1 例报告。
Methodist Debakey Cardiovasc J. 2022 Jul 12;18(1):54-58. doi: 10.14797/mdcvj.1076. eCollection 2022.
2
A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.一例对阿维A与乌司奴单抗联合治疗有效的难治性毛发红糠疹病例。
Dermatol Online J. 2020 Mar 15;26(3):13030/qt1712g0gm.
3
Refractory pityriasis rubra pilaris with good response after treatment with ustekinumab.使用优特克单抗治疗后反应良好的难治性毛发红糠疹
J Dtsch Dermatol Ges. 2018 Aug;16(8):1022-1025. doi: 10.1111/ddg.13550. Epub 2018 Jun 27.
4
Successful response of refractory type I adult-onset pityriasis rubra pilaris with ustekinumab and acitretin combination therapy.乌司奴单抗与阿维A联合治疗难治性成人型Ⅰ型毛发红糠疹取得成功
J Dermatol. 2015 Aug;42(8):830-1. doi: 10.1111/1346-8138.12927. Epub 2015 May 18.
5
Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.难治性毛发红糠疹用依那西普、阿达木单抗或乌司奴单抗治疗:一项回顾性研究。
Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12559. Epub 2017 Oct 15.
6
Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review.
J Am Acad Dermatol. 2018 Sep;79(3):585-587. doi: 10.1016/j.jaad.2018.02.063. Epub 2018 Mar 5.
7
Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases.乌司奴单抗治疗毛发红糠疹:五例报告。
J Dermatol. 2018 Feb;45(2):202-206. doi: 10.1111/1346-8138.14114. Epub 2017 Oct 28.
8
Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.红皮病型毛发红糠疹的治疗:两例病例报告及文献综述
Dermatol Ther. 2020 Nov;33(6):e14223. doi: 10.1111/dth.14223. Epub 2020 Sep 9.
9
Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?
Br J Dermatol. 2010 Oct;163(4):896-7; author reply 897-8. doi: 10.1111/j.1365-2133.2010.09942.x. Epub 2010 Sep 10.
10
Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series.
Australas J Dermatol. 2022 Nov;63(4):522-524. doi: 10.1111/ajd.13925. Epub 2022 Sep 21.

引用本文的文献

1
Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review.炎症性肠病患者的心脏代谢疾病:一项循证综述。
World J Gastroenterol. 2025 Jun 28;31(24):107661. doi: 10.3748/wjg.v31.i24.107661.
2
Gut-heart axis: cardiac remodeling and heart failure in the context of inflammatory bowel disease and dysbiosis.肠-心轴:炎症性肠病和肠道菌群失调背景下的心脏重塑与心力衰竭
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G122-G137. doi: 10.1152/ajpgi.00016.2025. Epub 2025 May 19.
3
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.

本文引用的文献

1
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?靶向白细胞介素 (IL)-12 和/或 IL-23 的生物制剂的心血管安全性:证据表明了什么?
Am J Clin Dermatol. 2021 Sep;22(5):587-601. doi: 10.1007/s40257-021-00612-9. Epub 2021 Jul 22.
2
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.乌司奴单抗在非适应证皮肤科疾病中的其他用途:系统评价。
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
3
Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia.
红癣:临床特征、发病机制及治疗选择的最新综述。
Am J Clin Dermatol. 2024 Mar;25(2):243-259. doi: 10.1007/s40257-023-00836-x. Epub 2023 Dec 30.
白细胞介素-17 通过在常氧和低氧条件下激活 STAT3 加重右心室重构。
BMC Cardiovasc Disord. 2021 May 21;21(1):249. doi: 10.1186/s12872-021-02069-4.
4
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab.早期严重心血管事件与抗白细胞介素 12/23p40 抗体乌司奴单抗治疗起始的相关性。
JAMA Dermatol. 2020 Nov 1;156(11):1208-1215. doi: 10.1001/jamadermatol.2020.2977.
5
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.乌司奴单抗治疗银屑病、银屑病关节炎和克罗恩病的安全性:Ⅱ/Ⅲ期临床开发项目的综合分析。
Drug Saf. 2019 Jun;42(6):751-768. doi: 10.1007/s40264-019-00797-3.
6
Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure.白细胞介素-17 通过激活 MAPK 通路增强缺血性心力衰竭中的心脏心室重构。
J Mol Cell Cardiol. 2018 Sep;122:69-79. doi: 10.1016/j.yjmcc.2018.08.005. Epub 2018 Aug 8.
7
Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis.与肿瘤坏死因子-α拮抗剂或环孢素相比,降低白细胞介素-12活性可改善银屑病患者的心肌和血管功能。
Circ Cardiovasc Imaging. 2017 Sep;10(9). doi: 10.1161/CIRCIMAGING.117.006283.
8
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.乌司奴单抗在中重度斑块状银屑病患者中的长期疗效和安全性:来自 PHOENIX 2 研究长达 5 年随访的结果。
Br J Dermatol. 2015;172(5):1371-83. doi: 10.1111/bjd.13469. Epub 2015 Mar 22.
9
IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.IL-17 和 Th17 细胞在动脉粥样硬化中的微妙及情境作用。
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):258-64. doi: 10.1161/ATVBAHA.114.303567. Epub 2014 Sep 18.
10
Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarction.白细胞介素-23 缺乏导致心肌梗死后伤口愈合受损和预后不良。
Circ Heart Fail. 2014 Jan;7(1):161-71. doi: 10.1161/CIRCHEARTFAILURE.113.000604. Epub 2013 Dec 3.